Skip to main content

Table 1 Baseline socio-demographic and clinical characteristics based on employment status of the study population (n = 1086)

From: Unemployment and work disability in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: a community-based cross-sectional study from Spain

 

Employed (n = 450)

Unemployed (n = 636)

P-valueb

Gender

  

0.959

 Female

405 (90.0)

573 (90.1)

 

 Male

45 (10.0)

63 (9.9)

 

Age group, years

  

0.004**

 ≤ 40

123 (27.3)

130 (20.4)

 

 41–50

182 (40.4)

246 (38.7)

 

 >  50

145 (32.2)

260 (40.9)

 

Age at onset, years

  

0.002**

 Fatigue

36 ± 10.3

37.8 ± 9.5

 

 Pain

36.6 ± 10.2

38.4 ± 9.6

 

Illness duration, years

9 ± 7.6

10.5 ± 8.6

0.839

Comorbid conditionsa

 Fibromyalgia

207 (46.0)

394 (62.0)

<  0.001***

 Degenerative vertebral disease

220 (49.0)

376 (59.3)

0.001***

 Epicondylitis

187 (41.6)

310 (48.9)

0.018*

 Ligamentous hyperlaxity

130 (28.9)

235 (37.1)

0.005**

 Multiple chemical hypersensitivity

135 (30.1)

230 (36.2)

0.035**

 Carpal tunnel syndrome

62 (13.8)

122 (19.2)

0.018*

Marital status

  

0.028**

 Married

272 (60.6)

428 (67.4)

 

 Single

107 (23.8)

107 (16.9)

 

 Separated/divorced

60 (13.4)

90 (14.2)

 

 Widow

10 (2.2)

10 (1.6)

 

Profession

  

<  0.001***

 Unskilled work

213 (47.3)

262 (41.2)

 

 Skilled work

105 (23.3)

179 (28.1)

 

 Administrative/office work

92 (20.4)

111 (17.5)

 

 Education/teaching

14 (3.1)

15 (2.4)

 

 Self-employed

7 (1.6)

7 (1.1)

 

 Liberal profession

16 (3.6)

23 (3.6)

 

 Arts and crafts

1 (0.2)

5 (0.8)

 

 Student

2 (0.4)

1 (0.2)

 

 Housewife

0 (0)

33 (5.2)

 

Educational level

  

0.506

 Elementary (primary) school

69 (15.3)

109 (17.1)

 

 Graduate

66 (14.7)

105 (16.5)

 

 High school/vocational training

188 (41.8)

248 (39.0)

 

 University

126 (28.0)

169 (26.6)

 

 Literate

1 (0.2)

5 (0.8)

 
  1. Data are given as numbers of cases (percentages) unless otherwise indicated
  2. *Significance at 0.05
  3. **Significance at 0.01
  4. ***Significance at 0.001
  5. a Because participants may report more than one comorbid illness, column numbers do not add up to the total sample. b Data analysis was performed using Chi-square test for categorical variables